173 related articles for article (PubMed ID: 33135528)
21. An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.
Soko ND; Chimusa E; Masimirembwa C; Dandara C
Pharmacogenomics J; 2019 Jun; 19(3):240-248. PubMed ID: 30100615
[TBL] [Abstract][Full Text] [Related]
22. Role of SLCO1B1, ABCB1, and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients.
Mei Y; Wang SY; Li Y; Yi SQ; Wang CY; Yang M; Duan KM
J Clin Pharmacol; 2015 Mar; 55(3):261-8. PubMed ID: 25279974
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
Campa D; Butterbach K; Slager SL; Skibola CF; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Kaaks R; Boffetta P; Brennan P; Conde L; Bracci PM; Caporaso NE; Strom SS; Camp NJ; Cerhan JR; ; Canzian F; Nieters A
Int J Cancer; 2012 Aug; 131(4):803-12. PubMed ID: 21918980
[TBL] [Abstract][Full Text] [Related]
24. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.
Loscocco F; Visani G; Ruzzo A; Bagaloni I; Fuligni F; Galimberti S; Di Paolo A; Stagno F; Pregno P; Annunziata M; Gozzini A; Barulli S; Gabucci E; Magnani M; Isidori A
Front Oncol; 2021; 11():672287. PubMed ID: 34055641
[TBL] [Abstract][Full Text] [Related]
25. ABC transporters are predictors of treatment failure in acute myeloid leukaemia.
Cerovska E; Salek C; Kundrat D; Sestakova S; Pesek A; Brozinova I; Belickova M; Remesova H
Biomed Pharmacother; 2024 Jan; 170():115930. PubMed ID: 38039756
[TBL] [Abstract][Full Text] [Related]
26. Influence of ABCC2, SLCO1B1, and ABCG2 polymorphisms on the pharmacokinetics of olmesartan.
Kim CO; Cho SK; Oh ES; Park MS; Chung JY
J Cardiovasc Pharmacol; 2012 Jul; 60(1):49-54. PubMed ID: 22494992
[TBL] [Abstract][Full Text] [Related]
27. Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy.
Megías-Vericat JE; Montesinos P; Herrero MJ; Moscardó F; Bosó V; Rojas L; Martínez-Cuadrón D; Rodríguez-Veiga R; Sendra L; Cervera J; Poveda JL; Sanz MÁ; Aliño SF
Pharmacogenomics J; 2018 Apr; 18(2):301-307. PubMed ID: 28485375
[TBL] [Abstract][Full Text] [Related]
28. ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients.
Chen S; Villeneuve L; Jonker D; Couture F; Laverdière I; Cecchin E; Innocenti F; Toffoli G; Lévesque E; Guillemette C
Pharmacogenet Genomics; 2015 Dec; 25(12):573-83. PubMed ID: 26352872
[TBL] [Abstract][Full Text] [Related]
29. Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.
Cousar JL; Conley YP; Willyerd FA; Sarnaik AA; Puccio AM; Empey PE; Kochanek PM; Bell MJ; Okonkwo DO; Clark RS
Neurocrit Care; 2013 Oct; 19(2):192-8. PubMed ID: 23896815
[TBL] [Abstract][Full Text] [Related]
30. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia.
Erdélyi DJ; Kámory E; Zalka A; Semsei AF; Csókay B; Andrikovics H; Tordai A; Borgulya G; Magyarosy E; Galántai I; Fekete G; Falus A; Szalai C; Kovács GT
Cell Immunol; 2006 Dec; 244(2):121-4. PubMed ID: 17434155
[TBL] [Abstract][Full Text] [Related]
31. Atorvastatin-associated myotoxicity: A toxicokinetic review of pharmacogenetic associations to evaluate the feasibility of precision pharmacotherapy.
Hoste E; Haufroid V; Deldicque L; Balligand JL; Elens L
Clin Biochem; 2024 Feb; 124():110707. PubMed ID: 38182100
[TBL] [Abstract][Full Text] [Related]
32. Co-expression of ATP binding cassette transporters is associated with poor prognosis in acute myeloid leukemia.
Liu B; Li LJ; Gong X; Zhang W; Zhang H; Zhao L
Oncol Lett; 2018 May; 15(5):6671-6677. PubMed ID: 29616130
[TBL] [Abstract][Full Text] [Related]
33. Coexpression of Multiple ABC-Transporters is Strongly Associated with Treatment Response in Childhood Acute Myeloid Leukemia.
Bartholomae S; Gruhn B; Debatin KM; Zimmermann M; Creutzig U; Reinhardt D; Steinbach D
Pediatr Blood Cancer; 2016 Feb; 63(2):242-7. PubMed ID: 26512967
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in drug transporter genes (ABCB1, SLCO1B1 and ABCC2) and hepatitis induced by antituberculosis drugs.
Kim SH; Kim SH; Lee JH; Lee BH; Kim YS; Park JS; Jee YK
Tuberculosis (Edinb); 2012 Jan; 92(1):100-4. PubMed ID: 22178260
[TBL] [Abstract][Full Text] [Related]
35. Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects.
Prado Y; Zambrano T; Salazar LA
J Clin Pharm Ther; 2018 Feb; 43(1):87-91. PubMed ID: 28833323
[TBL] [Abstract][Full Text] [Related]
36. Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response.
Wada M
Cancer Lett; 2006 Mar; 234(1):40-50. PubMed ID: 16377077
[TBL] [Abstract][Full Text] [Related]
37. Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
Jabir RS; Ho GF; Annuar MABA; Stanslas J
Clin Breast Cancer; 2018 Oct; 18(5):e1173-e1179. PubMed ID: 29885788
[TBL] [Abstract][Full Text] [Related]
38. An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure.
Vandell AG; Lee J; Shi M; Rubets I; Brown KS; Walker JR
Pharmacogenomics J; 2018 Jan; 18(1):153-159. PubMed ID: 27897269
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.
Cao HX; Miao CF; Yan L; Tang P; Zhang LR; Sun L
J Transl Med; 2017 Nov; 15(1):235. PubMed ID: 29141648
[TBL] [Abstract][Full Text] [Related]
40. Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke.
Zhang L; Lv H; Zhang Q; Wang D; Kang X; Zhang G; Li X
Curr Pharm Des; 2019; 25(14):1663-1670. PubMed ID: 31298164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
